by Melissa Burnett on April 30, 2012 in Research News
By: Erin Digitale, Stanford School of Medicine Leukemia, the most common form of childhood cancer, affects the blood-forming cells in the bone marrow. It is often treated with stem cell transplants that replace the patient’s bone marrow cells with stem cells … Continue reading →
by Melissa Burnett on April 24, 2012 in Research News
By: Kids Doctor, WFAA.com As a practicing pediatrician, I regularly participate in “grand rounds”. This is doctor lingo for a weekly teaching conference, and grand rounds occur on a regular basis in teaching hospitals all around the country. Recently, I … Continue reading →
by Melissa Burnett on April 4, 2012 in Research News
By: University of Virginia Health System The new Stem Cell Transplant Program at the University of Virginia Health System recently performed its first two stem cell transplants, using non-embryonic stem cells from umbilical cord blood. The program offers both bone marrow … Continue reading →
by Melissa Burnett on January 27, 2012 in Research News
By: U.S. Food and Drug Administration (FDA) Stem cell therapies offer the potential to treat diseases or conditions for which few treatments exist. Stem cells, sometimes called the body’s “master cells,” are the precursor cells that develop into blood, brain, bones … Continue reading →
by Melissa Burnett on January 19, 2012 in Research News
By Catharine Paddock PhD, Medical News Today Stem cells from cord blood “re-educated” the immune system T cells of people with type 1 diabetes so their pancreas started producing insulin again, thereby reducing the amount of insulin they needed to … Continue reading →
by Melissa Burnett on January 4, 2012 in LifeCord News, Partner Hospitals
By Elaine Rackley, Clayton News Daily, Jonesboro, GA One of two Georgia hospitals with LifeCord program – December 9, 2011 A stem cell program designed to aid medical research and help cancer patients, was started this week at Henry Medical Center. … Continue reading →
← Older posts